期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

三阴乳腺癌新辅助化疗研究进展 被引量：4

下载PDF
导出
摘要 1 三阴乳腺癌临床及病理特点乳腺癌是女性最常见的恶性肿瘤之一，并且是导致女性死亡的重要原因。而流行学研究数据将乳腺癌视为一个整体，未作具体分型研究，这种方法是不可取的，事实上不同类型乳腺癌预后有明显差异。相关统计发现，三阴乳腺癌（Triple-negative breast cancer，TNBC）多发于40岁以下绝经前非洲妇女，早孕、未哺乳和应用抑乳药物为其发生危险因素，其肿瘤大小、组织学分级、临床分期、淋巴结转移率均高于非三阴乳腺癌患者。
作者 刘骁蕾 王本忠
机构地区 安徽医科大学第一附属医院乳腺外科
出处 《安徽医学》 2011年第12期2094-2096,共3页 Anhui Medical Journal
关键词 乳腺肿瘤 三阴乳腺癌 新辅助化疗 化疗
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献29

  • 1Stead LA, Lash TL, Sobieraj JE, et al.Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res, 2009, 11:18.
  • 2Bertucci F, Finetti P, Cervera N, et al.Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Res, 2006, 66(9):4636-4644.
  • 3Nielsen TO,Hsu FD,Jensen K,et al.Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.Clin Cancer Res, 2004,10(16) : 5567-5374.
  • 4Kreike B, Horlings H, Weigelt B, et al.Gene expression profiling and histopathological characterization of triple-negative/ basal-like breast carcinomas. Breast Cancer Res, 2007, 9(5 ) :65.
  • 5Hurvitz SA, Finn RS. What's positive about 'triple-negative' breast cancer. Future Oncol, 2009, 5(7) : 1015-1025.
  • 6Morris GJ, Naidu S, Topham AK, et al. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance Epidemiology and End Results database. Cancer,2007, 110(4): 876-884.
  • 7Livasy CA, Karaca G, Nanda R, et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol,2006,19(2) :264-271.
  • 8Abd El-Rehim DM, Ball G, Pinder SE, et al. High-through- put protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer, 2005,116(3) : 340-350.
  • 9Gauthier ML, Berman HK, Miller C, et al. Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors. Cancer Cell, 2007,12(5) :479-491.
  • 10Cleator S, Heller W, Coombes RC, et al.Triple-negative breast cancer: therapeutic options. Lancet Oncol, 2007, 8(3): 235-244.

二级参考文献10

  • 1Rakha EA, El-Sayed ME, Green AR, et al. Prognostic markers in triple-negative breast cancer [ J ] . Cancer, 2007, 109(1): 25-32.
  • 2Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: Clinical features and patterns of recurrence [ J ] . Clin Cancer Res, 2007, 13(15):4429-4434.
  • 3Chang JC, Wooten EC, Tsimelzon A, et al. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer [ J ] . Lancet, 2003, 362(9381): 362-369.
  • 4Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours [ J ] . Nature, 2000, 406(6797): 747- 752.
  • 5Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets [ J ] . Proc Natl Acad Sci USA, 2003, 100(14): 8418- 8423.
  • 6Rouzier R, Perou CM, Symmans WF, et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy [J ] . Clin Cancer Res, 2005, 11(16): 5678- 5685.
  • 7Carey LA, Dees EC, Sawyer L, et al. The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes [ J ] . Clin Cancer Res, 2007, 13(8): 2329-2334.
  • 8Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer [ J ] . J Clin Oncol, 2008, 26(8): 1275-1281.
  • 9Livasy CA, Karaca G, Nanda R, et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma [ J ] . Mod Pathol, 2006, 19(2): 264-271.
  • 10Siziopikou KP, Ariga R, Proussaloglou KE, et al. The challenging estrogen receptor-negative/ progesterone receptor-negative/HER-2-negative patient: A promising candidate for epidermal growth factor receptor-targeted therapy? [ J ] . Breast J, 2006, 12(4): 360-362.

共引文献36

同被引文献28

  • 1毛杰,海健,舒衡平,唐利立,申正堂,邬玉辉,欧慧英.乳腺癌组织中survivin、c-erbB-2基因的表达与预后的关系[J].中国癌症杂志,2005,15(5):432-434. 被引量：8
  • 2费伯健,周士福,金留根,林奇.新辅助化疗对乳腺癌激素受体表达和状态的影响[J].南京医科大学学报（自然科学版）,2005,25(11):772-774. 被引量：18
  • 3Trotti A,Colevas D,Setser A. CTCAE v3.0.development of a comprehensive grading system for the adverse effects of cancer treatment[J].Seminars in Radiation Oncology,2003,(3):176-181.
  • 4周际昌.实用肿瘤内科学[M]北京人民卫生出版社,2002243-343.
  • 5Guan ZZ,Li QL,eng FY,eng FY. Superior efficacy of a Cremophor free albumin-bound paclitaxel compared with solvent-based paclitaxel in Chinese metastatic breast cancer[J].Asia Pac J Clin Oncol,2009,(3):159-174.
  • 6Liedtke C,Mazouni C,Hess KR. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer[J].Journal of Clinical Oncology,2008,(8):1275-1281.doi:10.1200/JCO.2007.14.4147.
  • 7Gralow JR,Bumtein HJ,Wood W. Preoperative therapy in invasive breast cancer:pathologic assessment and systemic therapy issues in operable disease[J].Journal of Clinical Oncology,2008,(05):814-819.
  • 8Mortimer J,Flournoy N,Livingston RB. Aggressive adri-amycin-containing Regimen(PM-FAC)inestrogen receptor-negative disseminated breast cancer[J].CANCER,1985,(10):2376-2380.
  • 9沈镇宙;邵志敏.现代乳腺肿瘤进展[M]上海:上海科学技术文献出版社,200287-89.
  • 10Henk HJ,Kaura S. Retrospective database analysis of the effect of zoledronic acid on skeletal-related events and mor-tality in women breast cancer and bone metastasis in a man-aged care plan[J].J Med Econ,2012,(15):175-184.

引证文献4

二级引证文献31

安徽医学
2011年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部